Safety and efficacy of the combination of the glucagon‐like peptide‐1 receptor agonist liraglutide with an oral antidiabetic drug in Japanese patients with type 2 diabetes: Post‐hoc analysis of a randomized, 52‐week, open‐label, parallel‐group trial

AIMS/INTRODUCTION: The aim of the present post‐hoc analysis was to investigate the safety and efficacy of liraglutide in combination with one oral antidiabetic drug (OAD) across different OAD classes. MATERIALS AND METHODS: This was a post‐hoc analysis using data from a 52‐week, open‐label, parallel...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiyosue, Arihiro, Seino, Yutaka, Nishijima, Keiji, Bosch‐Traberg, Heidrun, Kaku, Kohei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031500/
https://www.ncbi.nlm.nih.gov/pubmed/28984041
http://dx.doi.org/10.1111/jdi.12759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031500/
https://www.ncbi.nlm.nih.gov/pubmed/28984041
http://dx.doi.org/10.1111/jdi.12759

Ejemplares similares